Correlation Between Spyre Therapeutics and SavWatt USA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and SavWatt USA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and SavWatt USA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and SavWatt USA, you can compare the effects of market volatilities on Spyre Therapeutics and SavWatt USA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of SavWatt USA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and SavWatt USA.

Diversification Opportunities for Spyre Therapeutics and SavWatt USA

SpyreSavWattDiversified AwaySpyreSavWattDiversified Away100%
0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Spyre and SavWatt is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and SavWatt USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SavWatt USA and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with SavWatt USA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SavWatt USA has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and SavWatt USA go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and SavWatt USA

If you would invest  2,156  in Spyre Therapeutics on December 12, 2024 and sell it today you would lose (300.00) from holding Spyre Therapeutics or give up 13.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Spyre Therapeutics  vs.  SavWatt USA

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -35-30-25-20-15-10-50
JavaScript chart by amCharts 3.21.15SYRE SAVW
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar182022242628
SavWatt USA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days SavWatt USA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, SavWatt USA is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Spyre Therapeutics and SavWatt USA Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-6.79-5.08-3.38-1.68-0.02491.472.974.465.96 0.0050.0100.0150.0200.025
JavaScript chart by amCharts 3.21.15SYRE SAVW
       Returns  

Pair Trading with Spyre Therapeutics and SavWatt USA

The main advantage of trading using opposite Spyre Therapeutics and SavWatt USA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, SavWatt USA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SavWatt USA will offset losses from the drop in SavWatt USA's long position.
The idea behind Spyre Therapeutics and SavWatt USA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data